The structure of AAVrh32.33, a novel gene delivery vector

Journal of Structural Biology

Volumn 186, Issue 2, 2014, Pages 308-317

  Mikals, Kyle ^a   Nam, Hyun Joo ^a,c   Van Vliet, Kim ^a   Vandenberghe, Luk H ^b,d   Mays, Lauren E ^b   McKenna, Robert ^a   Wilson, James M ^b   Agbandje McKenna, Mavis ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c The University of Texas at Dallas   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AAVrh32.33; Adeno associated virus; Gene therapy; Parvovirus; Virus capsid structure; X ray crystallography

Indexed keywords

VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANTIBODY RESPONSE; ARTICLE; GENE TARGETING; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CAPSID; VIRUS MORPHOLOGY; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DEPENDOPARVOVIRUS; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; MOLECULAR GENETICS; PROTEIN CONFORMATION; ULTRASTRUCTURE;

ADENO-ASSOCIATED VIRUS; MACACA MULATTA; MIRIDAE; PARVOVIRUS;

AMINO ACID SEQUENCE; CAPSID; CRYSTALLOGRAPHY, X-RAY; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION;

EID: 84899928403     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2014.03.020     Document Type: Article

References (62)

1. Asokan A., Schaffer D.V., Samulski R.J. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 2012, 20:699-708.
2. Boutin S., Monteilhet V., Veron P., Leborgne C., Benveniste O., Montus M.F., Masurier C. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum. Gene Ther. 2010, 21:704-712.
3. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 1998, 54:905-921.
4. Buller R.M., Rose J.A. Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J. Virol. 1978, 25:331-338.
5. Calcedo R., Vandenberghe L.H., Gao G., Lin J., Wilson J.M. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J. Infect. Dis. 2009, 199:381-390.
6. Chapman M.S., Agbandje-Mckenna M. Atomic structure of viral particles. Parvoviruses 2006, 107-123. Hodder Arnold, London. J.R. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
7. DeLano W.L. The PyMOL Molecular Graphics System 2008, DeLano Scientific, Palo Alto, CA, USA, .
8. DiMattia M.A., Nam H.J., Van Vliet K., Mitchell M., Bennett A., Gurda B.L., McKenna R., Olson N.H., Sinkovits R.S., Potter M., Byrne B.J., Aslanidi G., Zolotukhin S., Muzyczka N., Baker T.S., Agbandje-McKenna M. Structural insight into the unique properties of adeno-associated virus serotype 9. J. Virol. 2012, 86:6947-6958.
9. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 2004, 60:2126-2132.
10. Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr. D 2010, 66:486-501.
11. Gao G., Vandenberghe L.H., Alvira M.R., Lu Y., Calcedo R., Zhou X., Wilson J.M. Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 2004, 78:6381-6388.
12. Gao G., Vandenberghe L.H., Wilson J.M. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 2005, 5:285-297.
13. Govindasamy L., Padron E., McKenna R., Muzyczka N., Kaludov N., Chiorini J.A., Agbandje-McKenna M. Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J. Virol. 2006, 80:11556-11570.
14. Govindasamy L., Dimattia M.A., Gurda B.L., Halder S., McKenna R., Chiorini J.A., Muzyczka N., Zolotukhin S., Agbandje-McKenna M. Structural insights into adeno-associated virus serotype 5. J. Virol. 2013, 87:11187-11199.
15. Grieger J.C., Snowdy S., Samulski R.J. Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly. J. Virol. 2006, 80:5199-5210.
16. Gurda B.L., Raupp C., Popa-Wagner R., Naumer M., Olson N.H., Ng R., McKenna R., Baker T.S., Kleinschmidt J.A., Agbandje-McKenna M. Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8. J. Virol. 2012, 86:7739-7751.
17. Gurda B.L., Dimattia M.A., Miller E.B., Bennett A., McKenna R., Weichert W.S., Nelson C.D., Chen W.J., Muzyczka N., Olson N.H., Sinkovits R.S., Chiorini J.A., Zolotutkhin S., Kozyreva O.G., Samulski R.J., Baker T.S., Parrish C.R., Agbandje-McKenna M. Capsid antibodies to different adeno-associated virus serotypes bind common regions. J. Virol. 2013, 87:9111-9124.
18. Halder S., Ng R., Agbandje-McKenna M. Parvoviruses: structure and infection. Future Virol. 2012, 253-278.
19. Huttner N.A., Girod A., Perabo L., Edbauer D., Kleinschmidt J.A., Buning H., Hallek M. Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther. 2003, 10:2139-2147.
20. Johnson F.B., Ozer H.L., Hoggan M.D. Structural proteins of adenovirus-associated virus type 3. J. Virol. 1971, 8:860-863.
21. Kaufmann B., Simpson A.A., Rossmann M.G. The structure of human parvovirus B19. Proc. Natl. Acad. Sci. USA 2004, 101:11628-11633.
22. Krissinel E., Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D 2004, 60:2256-2268.
23. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 1996, 8:477-486.
24. Lerch T.F., Xie Q., Chapman M.S. The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion. Virology 2010, 403:26-36.
25. Levy H.C., Bowman V.D., Govindasamy L., McKenna R., Nash K., Warrington K., Chen W., Muzyczka N., Yan X., Baker T.S., Agbandje-McKenna M. Heparin binding induces conformational changes in adeno-associated virus serotype 2. J. Struct. Biol. 2009, 165:146-156.
26. Li X., Cao H., Wang Q., Di B., Wang M., Lu J., Pan L., Yang L., Mei M., Pan X., Li G., Wang L. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice. Microbes Infect./Institut Pasteur 2012, 14:1000-1007.
27. Lin J., Calcedo R., Vandenberghe L.H., Bell P., Somanathan S., Wilson J.M. A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque. J. Virol. 2009, 83:12738-12750.
28. Lochrie M.A., Tatsuno G.P., Christie B., McDonnell J.W., Zhou S., Surosky R., Pierce G.F., Colosi P. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. J. Virol. 2006, 80:821-834.
29. Maguire A.M., High K.A., Auricchio A., Wright J.F., Pierce E.A., Testa F., Mingozzi F., Bennicelli J.L., Ying G.S., Rossi S., Fulton A., Marshall K.A., Banfi S., Chung D.C., Morgan J.I., Hauck B., Zelenaia O., Zhu X., Raffini L., Coppieters F., De Baere E., Shindler K.S., Volpe N.J., Surace E.M., Acerra C., Lyubarsky A., Redmond T.M., Stone E., Sun J., McDonnell J.W., Leroy B.P., Simonelli F., Bennett J. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009, 374:1597-1605.
30. Maheshri N., Koerber J.T., Kaspar B.K., Schaffer D.V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 2006, 24:198-204.
31. Mays L.E., Wilson J.M. Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopes. J. Gene Med. 2009, 11:1095-1102.
32. Mays L.E., Vandenberghe L.H., Xiao R., Bell P., Nam H.J., Agbandje-McKenna M., Wilson J.M. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins. J. Immunol. 2009, 182:6051-6060.
33. Mays L.E., Wang L., Tenney R., Bell P., Nam H.J., Lin J., Gurda B., Van Vliet K., Mikals K., Agbandje-McKenna M., Wilson J.M. Mapping the structural determinants responsible for enhanced T cell activation to the immunogenic adeno-associated virus capsid from isolate rhesus 32.33. J. Virol. 2013, 87:9473-9485.
34. McCraw D.M., O'Donnell J.K., Taylor K.A., Stagg S.M., Chapman M.S. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology 2012, 431:40-49.
35. McPherson A. Preparation and Analysis of Protein Crystals 1982, Wiley, New York, pp. 96-99. first ed.
36. Mingozzi F., High K.A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 2011, 12:341-355.
37. Mingozzi F., High K.A. Immune responses to AAV in clinical trials. Curr. Gene Ther. 2011, 11:321-330.
38. Moskalenko M., Chen L., van Roey M., Donahue B.A., Snyder R.O., McArthur J.G., Patel S.D. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J. Virol. 2000, 74:1761-1766.
39. Nam H.J., Lane M.D., Padron E., Gurda B., McKenna R., Kohlbrenner E., Aslanidi G., Byrne B., Muzyczka N., Zolotukhin S., Agbandje-McKenna M. Structure of adeno-associated virus serotype 8, a gene therapy vector. J. Virol. 2007, 81:12260-12271.
40. Nam H.J., Gurda B.L., McKenna R., Potter M., Byrne B., Salganik M., Muzyczka N., Agbandje-McKenna M. Structural studies of adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking. J. Virol. 2011, 85:11791-11799.
41. Nathwani A.C., Tuddenham E.G., Rangarajan S., Rosales C., McIntosh J., Linch D.C., Chowdary P., Riddell A., Pie A.J., Harrington C., O'Beirne J., Smith K., Pasi J., Glader B., Rustagi P., Ng C.Y., Kay M.A., Zhou J., Spence Y., Morton C.L., Allay J., Coleman J., Sleep S., Cunningham J.M., Srivastava D., Basner-Tschakarjan E., Mingozzi F., High K.A., Gray J.T., Reiss U.M., Nienhuis A.W., Davidoff A.M. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 2011, 365:2357-2365.
42. Navaza J. Implementation of molecular replacement in AMoRe. Acta Crystallogr. D 2001, 57:1367-1372.
43. Ng R., Govindasamy L., Gurda B.L., McKenna R., Kozyreva O.G., Samulski R.J., Parent K.N., Baker T.S., Agbandje-McKenna M. Structural characterization of the dual glycan binding adeno-associated virus serotype 6. J. Virol. 2010, 84:12945-12957.
44. O'Donnell J., Taylor K.A., Chapman M.S. Adeno-associated virus-2 and its primary cellular receptor - Cryo-EM structure of a heparin complex. Virology 2009, 385:434-443.
45. Otwinowski Z., Minor W. Methods Enzymol. 1997, 276:307-326.
46. Padron E., Bowman V., Kaludov N., Govindasamy L., Levy H., Nick P., McKenna R., Muzyczka N., Chiorini J.A., Baker T.S., Agbandje-McKenna M. Structure of adeno-associated virus type 4. J. Virol. 2005, 79:5047-5058.
47. Perabo L., Endell J., King S., Lux K., Goldnau D., Hallek M., Buning H. Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus. J. Gene Med. 2006, 8:155-162.
48. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
49. Pulicherla N., Shen S., Yadav S., Debbink K., Govindasamy L., Agbandje-McKenna M., Asokan A. Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Mol. Ther. 2011, 19:1070-1078.
50. Raupp C., Naumer M., Muller O.J., Gurda B.L., Agbandje-McKenna M., Kleinschmidt J.A. The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing. J. Virol. 2012, 86:9396-9408.
51. Rose J.A., Maizel J.V., Inman J.K., Shatkin A.J. Structural proteins of adenovirus-associated viruses. J. Virol. 1971, 8:766-770.
52. Schwede T., Kopp J., Guex N., Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003, 31:3381-3385.
53. Sonntag F., Bleker S., Leuchs B., Fischer R., Kleinschmidt J.A. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 2006, 80:11040-11054.
54. Tong L., Rossmann M.G. Rotation function calculations with GLRF program. Methods Enzymol. 1997, 276:594-611.
55. Vandenberghe L.H., Breous E., Nam H-J., Gao G., Xiao R., Sandhu A., Johnston J., Debyser Z., Agbandje-McKenna M., Wilson J.M. Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Ther. 2009, 16:1416-1428.
56. Venkatakrishnan B., Yarbrough J., Domsic J., Bennett A., Bothner B., Kozyreva O.G., Samulski R.J., Muzyczka N., McKenna R., Agbandje-McKenna M. Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking. J. Virol. 2013, 87:4974-4984.
57. Wang L., Calcedo R., Nichols T.C., Bellinger D.A., Dillow A., Verma I.M., Wilson J.M. Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood 2005, 105:3079-3086.
58. Wobus C.E., Hugle-Dorr B., Girod A., Petersen G., Hallek M., Kleinschmidt J.A. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 2000, 74:9281-9293.
59. Xiao C., Rossmann M.G., M.G. Interpretation of electron density with stereographic roadmap projections. J. Struct. Biol. 2007, 158:182-187.
60. Xie Q., Bu W., Bhatia S., Hare J., Somasundaram T., Azzi A., Chapman M.S. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA 2002, 99:10405-10410.
61. Xie Q., Lerch T.F., Meyer N.L., Chapman M.S. Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6). Virology 2011, 420:10-19.
62. Yang Z., Lasker K., Schneidman-Duhovny D., Webb B., Huang C.C., Pettersen E.F., Goddard T.D., Meng E.C., Sali A., Ferrin T.E. UCSF Chimera, MODELLER, and IMP: an integrated modeling system. J. Struct. Biol. 2012, 179:269-278.